Xilio Therapeutics XLO
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 8.96 | -114.25 | 1.83 | -11,836 | 10 | |
| 2025Q3 | 11.80 | 11.84 | -1.26 | -1,929 | -16 | |
| 2025Q2 | 9.52 | 90.67 | -2.24 | -14,366 | -16 | |
| 2025Q1 | 10.14 | 104.42 | -2.52 | -13,851 | -13 | |
| 2024Q4 | 13.37 | 104.09 | -2.50 | -13,629 | -13 | |
| 2024Q3 | 11.03 | 105.29 | -2.52 | -14,762 | -14 | |
| 2024Q2 | 13.27 | 105.59 | -1.54 | -14,704 | -14 | |
| 2024Q1 | 15.12 | 101.65 | -8.68 | -17,487 | -17 | |
| 2023Q4 | 7.70 | 102.69 | -8.96 | -18,130 | -18 | |
| 2023Q3 | 29.54 | 103.66 | -8.54 | -17,361 | -17 | |
| 2023Q2 | 36.68 | 103.93 | -9.80 | -20,116 | -19 | |
| 2023Q1 | 44.38 | 103.89 | -11.62 | -23,526 | -23 | |
| 2022Q4 | 37.66 | 103.12 | -11.48 | -23,167 | -22 | |
| 2022Q3 | 40.74 | 102.10 | -10.08 | -20,206 | -20 | |
| 2022Q2 | 40.88 | 99.75 | -12.60 | -24,552 | -25 | |
| 2022Q1 | 98.98 | 99.40 | -10.92 | -21,224 | -21 | |
| 2021Q4 | 224.00 | 99.26 | 877.22 | -19,556 | -20 | |
| 2021Q3 | 98.22 | -294.27 | -15,961 | -16 | ||
| 2021Q2 | -23,007 | -23 | ||||
| 2021Q1 | -8.75 | -16,520 | -17 |